SML3709
Tosufloxacin tosylate
≥98% (HPLC)
Synonym(s):
7-(3-Amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid 4-methylbenzenesulfonate, A 64730, A-61827, T 3262
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C19H15F3N4O3·C7H8O3S
CAS Number:
Molecular Weight:
576.54
UNSPSC Code:
12352200
NACRES:
NA.21
MDL number:
Quality Level
assay
≥98% (HPLC)
form
powder
storage condition
desiccated
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
-10 to -25°C
Related Categories
Biochem/physiol Actions
Synthetic fluoroquinolone broad spectrum antibiotic
Tosufloxacin tosylate is a synthetic fluoroquinolone broad spectrum antibiotic. Tosufloxacin potently inhibits bacterial DNA gyrase and topoisomerase IV. Tosufloxacin is indicated for the treatment of various infections such as skin, respiratory, urinary, gynecologic, ophthalmologic, otolaryngologic, dental infections.
Disclaimer
Hygroscopic
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
M A Cooper et al.
The Journal of antimicrobial chemotherapy, 29(6), 639-647 (1992-06-01)
The in-vitro activity of tosufloxacin (A-61827) was compared with that of temafloxacin, ciprofloxacin and selected members of other groups of antimicrobial agents, against 684 recent distinct clinical isolates and strains with known mechanisms of resistance. Against members of the Enterobacteriaceae
Masaru Usui et al.
Antimicrobial agents and chemotherapy, 63(6) (2019-04-03)
Formation of bacterial biofilms is a major health threat due to their high levels of tolerance to multiple antibiotics and the presence of persisters responsible for infection relapses. We previously showed that a combination of starvation and induction of SOS
Pengfei She et al.
Current microbiology, 79(1), 12-12 (2021-12-15)
Pseudomonas aeruginosa is a ubiquitous bacterium found in hospitals and the surrounding environment. The ability of P. aeruginosa to form biofilms confers high-level resistance to antibiotics, and the persister cells formed in the presence of high antibacterial drug concentrations make
Global Trade Item Number
| SKU | GTIN |
|---|---|
| SML3709-10MG | 04065269267768 |
| SML3709-50MG | 04065269267775 |
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service